• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个用于基于分层Cox回归模型估计直接调整生存曲线的SAS宏。

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

作者信息

Zhang Xu, Loberiza Fausto R, Klein John P, Zhang Mei-Jie

机构信息

Department of Mathematics and Statistics, Georgia State University, Atlanta, GA 30303, USA.

出版信息

Comput Methods Programs Biomed. 2007 Nov;88(2):95-101. doi: 10.1016/j.cmpb.2007.07.010. Epub 2007 Sep 11.

DOI:10.1016/j.cmpb.2007.07.010
PMID:17850917
Abstract

Often in biomedical research the aim of a study is to compare the outcomes of several treatment arms while adjusting for multiple clinical prognostic factors. In this paper we focus on computation of the direct adjusted survival curves for different treatment groups based on an unstratified or a stratified Cox model. The estimators are constructed by taking the average of the individual predicted survival curves. The method of direct adjustment controls for possible confounders due to an imbalance of patient characteristics between treatment groups. This adjustment is especially useful for non-randomized studies. We have written a SAS macro to estimate and compare the direct adjusted survival curves. We illustrate the SAS macro through the examples analyzing stem cell transplant data and Ewing's sarcoma data.

摘要

在生物医学研究中,一项研究的目的通常是在对多个临床预后因素进行调整的同时,比较几个治疗组的结果。在本文中,我们专注于基于未分层或分层的Cox模型计算不同治疗组的直接调整生存曲线。估计量是通过对个体预测生存曲线取平均值来构建的。直接调整方法可控制由于治疗组之间患者特征不平衡而可能产生的混杂因素。这种调整对于非随机研究特别有用。我们编写了一个SAS宏来估计和比较直接调整生存曲线。我们通过分析干细胞移植数据和尤因肉瘤数据的例子来说明这个SAS宏。

相似文献

1
A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.一个用于基于分层Cox回归模型估计直接调整生存曲线的SAS宏。
Comput Methods Programs Biomed. 2007 Nov;88(2):95-101. doi: 10.1016/j.cmpb.2007.07.010. Epub 2007 Sep 11.
2
Adjusted survival curves with inverse probability weights.采用逆概率加权法调整后的生存曲线。
Comput Methods Programs Biomed. 2004 Jul;75(1):45-9. doi: 10.1016/j.cmpb.2003.10.004.
3
Predictive survival model with time-dependent prognostic factors: development of computer-aided SAS Macro program.具有时间依赖性预后因素的预测生存模型:计算机辅助SAS宏程序的开发
J Eval Clin Pract. 2005 Apr;11(2):181-93. doi: 10.1111/j.1365-2753.2005.00519.x.
4
SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.基于竞争风险生存数据的Cox回归模型估计累积发病率函数的SAS宏。
Comput Methods Programs Biomed. 2004 Apr;74(1):69-75. doi: 10.1016/S0169-2607(03)00069-5.
5
A SAS-macro for estimation of the cumulative incidence using Poisson regression.一个用于使用泊松回归估计累积发病率的SAS宏。
Comput Methods Programs Biomed. 2009 Feb;93(2):140-7. doi: 10.1016/j.cmpb.2008.08.004. Epub 2008 Oct 15.
6
Time-dependent predictors in clinical research, performance of a novel method.临床研究中的时间依赖性预测因子,一种新方法的性能。
Am J Ther. 2010 Nov-Dec;17(6):e202-7. doi: 10.1097/MJT.0b013e3181d5e411.
7
Survival of primary and repeat lung transplantation in the United States.美国初次及再次肺移植的生存率
Ann Thorac Surg. 2009 Jan;87(1):261-6. doi: 10.1016/j.athoracsur.2008.10.031.
8
Introduction to the use of regression models in epidemiology.流行病学中回归模型的应用介绍。
Methods Mol Biol. 2009;471:179-95. doi: 10.1007/978-1-59745-416-2_9.
9
Adjusting survival curves for confounders: a review and a new method.针对混杂因素调整生存曲线:综述与一种新方法。
Am J Epidemiol. 1996 May 15;143(10):1059-68. doi: 10.1093/oxfordjournals.aje.a008670.
10
Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods.使用多变量Cox比例风险回归和倾向评分方法进行调整后比较治疗效果。
Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):1-8. doi: 10.1002/pds.1520.

引用本文的文献

1
Survival analysis of Kasturi tobacco plants in Jember district using the stratified cox and extended cox models.使用分层Cox模型和扩展Cox模型对任抹县卡斯特里烟草植株进行生存分析。
MethodsX. 2025 May 27;14:103400. doi: 10.1016/j.mex.2025.103400. eCollection 2025 Jun.
2
Longitudinal Changes in Cardiovascular-Kidney-Metabolic Syndrome Stages and Their Impact on Outcomes: A Nationwide Cohort Study.心血管-肾脏-代谢综合征阶段的纵向变化及其对结局的影响:一项全国性队列研究。
J Clin Med. 2025 Jun 1;14(11):3888. doi: 10.3390/jcm14113888.
3
A New Biomarker of Aging Derived From Electrocardiograms Improves Risk Prediction of Incident Cardiovascular Disease.
一种源自心电图的新型衰老生物标志物可改善心血管疾病发病风险预测。
JACC Adv. 2025 May 13;4(6 Pt 1):101764. doi: 10.1016/j.jacadv.2025.101764.
4
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703.基于移植后环磷酰胺的移植物抗宿主病预防对70岁及以上患者的影响:BMT CTN 1703的最新情况
Blood Adv. 2025 Apr 30. doi: 10.1182/bloodadvances.2025015964.
5
Adjusted curves for clustered survival and competing risks data.聚类生存和竞争风险数据的调整曲线。
Commun Stat Simul Comput. 2025;54(1):120-143. doi: 10.1080/03610918.2023.2245583. Epub 2023 Aug 16.
6
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?影响局限性肾细胞癌预后所需的肉瘤样成分的最小百分比是多少?
BJU Int. 2025 May;135(5):818-827. doi: 10.1111/bju.16609. Epub 2024 Dec 4.
7
Mortality, Hospitalization, and Cardiac Interventions in Patients With Atrial Fibrillation Aged <65 Years.年龄<65 岁的心房颤动患者的死亡率、住院率和心脏介入治疗。
Circ Arrhythm Electrophysiol. 2024 May;17(5):e012143. doi: 10.1161/CIRCEP.123.012143. Epub 2024 Apr 22.
8
Representativeness of the PIONEER-HF and PARAGLIDE-HF in patients hospitalized with acute heart failure.PIONEER-HF 和 PARAGLIDE-HF 研究中住院急性心力衰竭患者的代表性。
ESC Heart Fail. 2024 Aug;11(4):2259-2271. doi: 10.1002/ehf2.14761. Epub 2024 Apr 18.
9
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.原发中枢弥漫性大 B 细胞淋巴瘤患者行自体造血干细胞移植时,噻替哌剂量强度对其与卡莫司汀联合预处理方案的影响。
Bone Marrow Transplant. 2023 Nov;58(11):1203-1208. doi: 10.1038/s41409-023-02071-8. Epub 2023 Aug 10.
10
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.移植后环磷酰胺为基础的移植物抗宿主病预防。
N Engl J Med. 2023 Jun 22;388(25):2338-2348. doi: 10.1056/NEJMoa2215943.